HAL fluorescence cystoscopy: towards a new paradigm in bladder cancer management

Patrice Jichlinski

doi:10.1117/12.828216

13 July 2009 HAL fluorescence cystoscopy: towards a new paradigm in bladder cancer management

Patrice Jichlinski

Proceedings Volume 7380, Photodynamic Therapy: Back to the Future; 738033 (2009) https://doi.org/10.1117/12.828216
Event: 12th World Congress of the International Photodynamic Association, 2009, Seattle, Washington, United States

Abstract

Hexaminolevulinate fluorescence cystoscopy by the addition of a specific tissue fluorophore enhances the contrast between benign and malignant epithelial (urothelial) cells in the bladder. Improved detection of flat and papillary tumors as confirmed in recent phase III clinical trials allows the urologist to obtain a precise information on the disease extent at the whole surface of the bladder wall. With gaining experience, management of non muscle invasive bladder cancer improves in readiness and accuracy.

Citation Download Citation

Patrice Jichlinski "HAL fluorescence cystoscopy: towards a new paradigm in bladder cancer management", Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 738033 (13 July 2009); https://doi.org/10.1117/12.828216

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available